Open Access

PCSK9 inhibitors: the story continues.

Congress Session

About the speaker

Professor John Chapman

Medical Faculty, Sorbonne University, Pitie-Salpetriere University hospital, Paris (France)
15 presentations
0 follower

2 more presentations in this session

Challenging the data.

Speaker: Professor J. Chapman (Paris, FR) Professor P. Sever (London, GB)

Thumbnail

PCSK9 inhibitors: more volumes to come?

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Access the full session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention

Speakers: Professor J. Chapman, Professor J. Chapman, Professor P. Sever, Professor J. Chapman
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk